Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other Accumulated Expenses (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Other Accumulated Expenses readings, the most recent being $2.2 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 6.18% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 6.18% increase, with the full-year FY2025 number at $2.2 million, up 6.18% from a year prior.
  • Other Accumulated Expenses hit $2.2 million in Q4 2025 for Treace Medical Concepts, down from $2.5 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $4.5 million in Q1 2024 to a low of $1.1 million in Q4 2021.
  • Median Other Accumulated Expenses over the past 5 years was $2.8 million (2025), compared with a mean of $2.8 million.
  • Biggest five-year swings in Other Accumulated Expenses: surged 144.9% in 2021 and later tumbled 48.24% in 2024.
  • Treace Medical Concepts' Other Accumulated Expenses stood at $1.1 million in 2021, then skyrocketed by 64.63% to $1.8 million in 2022, then surged by 123.4% to $4.0 million in 2023, then plummeted by 48.24% to $2.1 million in 2024, then rose by 6.18% to $2.2 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $2.2 million (Q4 2025), $2.5 million (Q3 2025), and $2.8 million (Q2 2025) per Business Quant data.